Synthesis and antibacterial activity of catecholate-ciprofloxacin conjugates. 2014

Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
Laboratoire de Glycochimie, des Antimicrobiens, et des Agroressources, CNRS FRE 3517, UFR de Pharmacie, Université de Picardie Jules Verne, F-80037 Amiens, France.

The development of an efficient route to obtain artificial siderophore-antibiotic conjugates active against Gram-negative bacteria is crucial. Herein, a practical access to triscatecholate enterobactin analogues linked to the ciprofloxacin along with their antibacterial evaluation are described. Two series of conjugates were obtained with and without a piperazine linker which is known to improve the pharmacokinetics profile of a drug. A monocatecholate-ciprofloxacin conjugate was also synthesized and evaluated. The antibacterial activities against Pseudomonas aeruginosa for some conjugates are related to the iron concentration in the culture medium and seem to depend on the bacterial iron uptake systems.

UI MeSH Term Description Entries
D007502 Iron Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. Iron Chelates,Agents, Iron Chelating,Chelates, Iron,Chelating Agents, Iron
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002396 Catechols A group of 1,2-benzenediols that contain the general formula R-C6H5O2. Pyrocatechols,o-Dihydroxybenzenes,ortho-Dihydroxybenzenes,o Dihydroxybenzenes,ortho Dihydroxybenzenes
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
September 2020, ACS combinatorial science,
Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
February 2005, Yao xue xue bao = Acta pharmaceutica Sinica,
Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
August 2023, Dalton transactions (Cambridge, England : 2003),
Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
August 2007, Yao xue xue bao = Acta pharmaceutica Sinica,
Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
March 2009, Bioorganic & medicinal chemistry letters,
Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
June 2018, Acta pharmaceutica (Zagreb, Croatia),
Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
March 2009, Bioorganic & medicinal chemistry letters,
Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
December 2016, Yao xue xue bao = Acta pharmaceutica Sinica,
Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
August 1998, The Journal of antibiotics,
Sylvain Fardeau, and Alexandra Dassonville-Klimpt, and Nicolas Audic, and André Sasaki, and Marine Pillon, and Emmanuel Baudrin, and Catherine Mullié, and Pascal Sonnet
September 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!